People: Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

2.38USD
15 Sep 2014
Price Change (% chg)

$-0.08 (-3.25%)
Prev Close
$2.46
Open
$2.45
Day's High
$2.45
Day's Low
$2.36
Volume
506,845
Avg. Vol
705,042
52-wk High
$7.34
52-wk Low
$1.31

Search Stocks

Kelly Behrs, Melissa 

Brief Biography

Ms. Melissa A. Kelly Behrs is Executive Vice President - Portfolio and Alliance Management of the Company. She previously served as Senior Vice President, Strategic Portfolio Management and Product Development and Manufacturing, since May 2011. She served as Senior Vice President, Therapeutic Development, Oncology, from January 2007 until May 2011, and as Vice President, Oncology from January 2003 until January 2007. From April 2002 until January 2003, Ms. Behrs served as Vice President, Corporate Development. Ms. Behrs worked at Genetics Institute, Inc., a biotechnology research and development company, serving initially as Assistant Treasurer and then as Associate Director of Preclinical Operations where she was responsible for all business development, regulatory, and project management activities for the Preclinical Development function. Ms. Behrs received a B.S. from Boston College and an M.B.A. from Babson College.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
341,550 -- 604,706 946,256

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Hoyoung Huh

--

John Scarlett

2,278,340

Olivia Bloom

957,156

Stephen Rosenfield

883,374

Andrew Grethlein

866,575

Melissa Kelly Behrs

946,256
As Of 30 Dec 2013
Search Stocks